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I NTRO D U C TIO N
Brugada syndrome (BrS) is characterised by ST segment elevation (coved type) in the right precordial leads on electrocardiography (ECG), and sudden cardiac death in patients with a structurally normal heart. In Thailand, it was discovered that many post-resuscitated patients had a Brugada ECG and a family history of sudden unexplained death syndrome (SUDS).
(1) BrS typically manifests during adulthood, with sudden death occurring at a mean age of 41 ± 15 years, and ventricular tachycardia (VT) or ventricular fibrillation (VF occurring predominantly at rest or during sleep. (1) (2) (3) (4) (5) A Brugada ECG or a coved-type ECG pattern is key in the diagnosis of
BrS. This ECG pattern may be found in persons with a family history of SUDS or in asymptomatic persons. Several methods, such as a postexercise examination, medications (e.g. sodium channel-blocking agents) and the use of high intercostal leads, can be used to unmask the Brugada ECG. (6, 7) Early detection of Brugada ECG may indicate risks of developing SUDS or sudden cardiac arrest (SCA).
For symptomatic BrS patients, treatment with an implantable cardioverter defibrillator (ICD) is more effective than the use of antiarrhythmic drugs. (8) Currently, ICD implantation is the standard treatment for secondary prevention in symptomatic BrS patients, including aborted SCA and syncope of unknown origin. (9) Data on the clinical characteristics and treatment outcomes of patients with BrS and asymptomatic patients with Brugada ECG is still limited. We therefore conducted a study on a large series of patients with BrS from northeastern Thailand, an area endemic for BrS, and herein report our findings. Brugada ECG was defined as a prominent coved ST segment elevation (i.e. > 2 mm) followed by a negative T wave. (10) (11) (12) Patients who were asymptomatic and had a Brugada ECG were categorised into the asymptomatic group. The following clinical data were collected: age at diagnosis, gender, birth place, 
M E TH O DS

R E SU lT S
A total of 90 eligible patients (mean age 46.00 ± 5.64 years)
were enrolled during the study period. The demographic and clinical characteristics of the study population are summarised in 
D I SCU S S IO N
In the present study, we found that the demographic and clinical characteristics (i.e. age, gender, family history of sudden death, ECG type and area of residence) of symptomatic BrS patients and asymptomatic patients with Brugada ECG did not differ significantly (Table I ). Almost all of the patients were male and resided in northeastern Thailand.
Asymptomatic patients with Brugada ECG had a higher ratio of family history of sudden death. Family members of BrS patients are urged to undergo a 12-channel ECG test with high intercostal leads or medications to detect Brugada ECG. The prevalence of a family history of SCA in the symptomatic BrS patients in our study was higher than that reported in a study from Europe (29.1% vs 9.1%). (13) In the present study, 20.3% of the Brugada ECGs in symptomatic
BrS patients was unmasked with the use of high intercostal leads. This finding is compatible with a previous report by Sangwatanaroj et al, (5) In which, the authors recommended that family members of victims of SUDS be screened using ECG with high intercostal leads. (5) However, further studies are needed to justify such a screening exercise.
The clinical characteristics and treatment outcomes of symptomatic BrS patients who presented with SCA and unexplained syncope were comparable in the present study (Tables II & III) . Almost all of the symptomatic BrS patients underwent ICD implantation (76/79, 96.2%). Of these 76 patients, 25 (32.8%) received appropriate shock therapy.
This number is 4.2 times the number of patients who received inappropriate shocks (n = 6). In contrast, a study by Sacher et al (14) found that inappropriate shocks occurred 2.5 times more frequently than appropriate shock therapy. This difference may be due to differences in the study population of the two studies; the present study had more patients with documented SCA than the study by Sacher et al (82.3% vs 8%).
In our study, at least 31.6% (25/79) of the symptomatic BrS patients reaped the benefits of ICD implantation in preventing further VT/VF. The shock therapies occurred mainly during the 
